Vanderbilt-Ingram Cancer Center

By Dagny Stuart A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening. The study was presented by Stephen A. Deppen, M.A., M.S., [...]

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to a leadership role of two newly created cancer research initiatives at Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer Center Research Network (VICCRN). The CCTT [...]

Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, and professor and Acting Chair of Cancer Biology, and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th Annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. He received the award April 7 during the AACR Annual Meeting [...]

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt University School of Medicine, has been chosen president-elect for 2013-2014 of the American Association for Cancer Research. Arteaga, who holds the Donna S. Hall Chair in Breast Cancer, also serves as associate director for clinical research and director of the Breast Cancer Research [...]

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. The study, led by first author Matthew Resnick, M.D., instructor in Urologic Surgery, Vanderbilt University Medical Center, was [...]

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. This is the largest number of Vanderbilt fellows to be elected in a single year. Vanderbilt University now has 80 AAAS fellows among its current and emeritus faculty. Vanderbilt’s fellows are among 702 [...]

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). “We decided to roll the dice and propose high-risk, high-reward projects,” said Robert Coffey Jr., M.D., Ingram Professor of Cancer Research, professor of Medicine and Cell and Developmental Biology, and director [...]

A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D., MPH, assistant professor of Urologic [...]

Glioma is the most common and lethal type of brain tumor, and now investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. The variant also appears to improve the odds of survival among glioma patients. Reid Thompson, M.D., William [...]

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer. He will receive $300,000 over three years in support of his research efforts. Hassanein, who specializes in molecular biology and genetics, works in the [...]